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Characterization of a functional serum response element in the
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The serum response factor (SRF) activates expression of
several genes in response to growth factors present in
serum. SRF also regulates the expression of tissue-specific
genes, including those in vertebrate muscles. An SRF-
binding site (CArG box) present in the Artemia franciscana
Actin403 promoter was shown to be necessary for
transcriptional activity in cultured cells from Drosophila
melanogaster and mammals. This DNA region bound
mammalian and Drosophila SRFs in vitro and mediated
transcriptional activation of the Actin403 promoter in
response to serum, phorbol esters and lysophosphatidic
acid in transfected cultured mammalian cells. Mutations in
the CArG box greatly reduced promoter activity and
stimulation by extracellular compounds.
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The crustacean Artemia franciscana develops through a
biological cycle characterized by the possible existence of
cryptobiotic embryos, also named cysts [1]. These resis-
tance forms are produced when embryos, at the gastrula
stage, interrupt their metabolism and development, become
surrounded by a hard shell, and are released from the
maternal ovisac to the external medium. These embryos
remain viable for years. Placed under favorable conditions,
the cysts reinitiate development in a complex process that
requires an activation step followed by hydration and
resumption of metabolism and embryonic development [2].
Several functions are activated during this process,
including gene transcription. Studies of steady-state
expression levels of several mRNAs revealed transcription
activity 2±4 h after cysts had resumed development [3,4].
The mechanisms that regulate transcription activation are
largely unknown, although some possibilities have been
proposed, such as activation of the transcriptional
machinery through an increase in intracellular pH [5] and
induction and/or activation of transcription factors [6,7].
The Actin403 gene, coding for one of four actin isoforms
identified in A. franciscana, is transcribed a few hours after
cyst development begins, with a sixfold increase in mRNA
levels between 4±16 h of cyst growth [4]. Actin403 mRNA
is expressed in ectodermic tissues of the embryo including
the epidermis, foregut and hindgut [7]. Genomic clones
containing the complete coding region and the promoter
region of the Actin403 gene have been isolated [8].
Analysis of the nucleotide sequence of the promoter
indicated the presence of a putative CArG box, a region
with a nucleotide sequence very similar to the consensus
binding site of the vertebrate serum response factor (SRF).
The possible relevance of this element in regulation of
Actin403 expression was suggested by the observation that
an A. franciscana SRF homolog exhibited a similar pattern
of mRNA expression as Actin403 in the embryos [7].
The transcription factor, SRF, plays important roles in
several processes in vertebrates, including cell proliferation
[9], muscle cell differentiation [10], and mesoderm
induction [11]. In cultured cells, SRF activity is dependent
on cell activation by growth factors. These signals are
transduced to SRF through phosphorylation of cofactors of
the Ets family of transcription factors, named ternary
complex factors (TCFs), by mitogen-activated protein
kinases [9,12]. Binding of phosphorylated TCF to SRF on
the promoter triggers gene transcription. Alternatively, SRF
can be activated by extracellular signals through weakly
defined TCF-independent pathways [12].
The available data make Actin403 one of the more
interesting genes to study from the perspective of
transcriptional regulation during A. franciscana cyst
development. The analysis of this gene is continued here
by characterization of promoter region functional elements.
The absence of cultured A. franciscana cell lines and the
inability to incorporate exogenous DNA into the organism
necessitated the use of cultured mammalian and Drosophila
cells in these studies. The data obtained demonstrate the
functionality of the CArG box in this promoter and its
conserved regulation in mammalian cells.
M A T E R I A L S A N D M E T H O D S
DNA constructs
Actin403 promoter-luciferase reporter vectors. The largest
Actin403 promoter fragment (21362 to 238) was gener-
ated by PCR from the original genomic clone [8] and
inserted upstream of the luciferase gene in the reporter
vector pXP2 [13]. Progressive deletions from the 5 0 end of
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the fragment were achieved by the exonuclease III,
nuclease S1 method [14]. The D6 deletion of the
Actin403 promoter (2176 to 238) was used as substrate
to generate a double mutation in the CArG box [15]. The
oligonucleotide 5 0-ACATGAACATACAAGGTATTGC-3 0
and the universal sequencing primers were used as primers
in the PCRs required to generate this mutation. The
nucleotide sequences of all fragments generated by PCR
were determined to confirm that no polymerase errors were
introduced. The Taq dye deoxyterminator cycle sequencing
kit and an Applied Biosystems 373A sequencer were used
to determine nucleotide sequences.
Cell lines and transfections
Monkey kidney Bsc40 cells and mouse fibroblast NIH3T3
cells were maintained in Dulbecco's modified Eagle's
medium supplemented with 10% newborn bovine serum
and 2 mm glutamine. Mouse teratocarcinoma F9 cells were
maintained in a 1 : 1 mixture of Dulbecco's modified
Eagle's medium and Ham's medium, supplemented with
10% fetal bovine serum and 2 mm glutamine. Drosophila
Schneider cells were cultured in M3 medium (Gibco-BRL)
with 10% fetal bovine serum, supplemented with penicillin
and streptomycin, at 25 8C. Cells were transfected by the
calcium phosphate precipitation method in 60-mm dishes
[16,17]; 5 mg luciferase reporter vectors and 1 mg of the
b-galactosidase expression vector pCMVb (Clontech
Laboratory Inc., Palo Alto, CA, USA) were transfected
per plate. In Schneider cells, 10 mg pSVbgal were used
instead of pCMVb. Cells were harvested 48±72 h after
transfection, and b-galactosidase activities determined [18].
Luciferase activity was determined with a commercial kit
(Promega) according to the manufacturer's instructions.
Transfection efficiencies were corrected by obtaining the
luciferase/b-galactosidase ratio for each sample. Each
experiment was repeated at least three times, with duplicate
samples. Means ^ SD are presented in the figures.
Transfected cells in stimulation experiments were changed
to Dulbecco's modified Eagle's medium supplemented with
0.5% fetal bovine serum 15±16 h after transfection and
kept in this medium for 24 h. After this period of serum
depletion, cells were stimulated by the addition of
serum (10% fetal bovine serum for F9 and NIH3T3 cells,
20% for Bsc40 cells), phorbol 12,13-dibutyrate (PDBu;
350 nm for F9 and NIH3T3 cells, 700 nm for Bsc40 cells),
or lysophosphatidic acid (LPA; 20 mm for F9 and NIH3T3
cells, 40 mm for Bsc40 cells). Cells were harvested after
6±8 h of stimulation. Control dishes were maintained in
0.5% fetal bovine serum until harvesting. Luciferase
activities were not corrected for b-galactosidase activity
in the stimulation experiments. Statistical analyses were
performed with the prism 2.0 program, using the one-way
anova and Turkey tests. The statistical significance of
activities observed after each treatment, compared with
control cells maintained in low serum, are indicated in
Figs 2 and 4.
Electrophoretic mobility-shift assay (EMSA)
Nuclear extracts of NIH3T3 and Schneider cells were
prepared [19], and 10 mg incubated with 1±3 ng
32P-labeled double-stranded oligonucleotide serum response
element (SRE; 5 0-ACATGACCATATAAGGTATTGCA-
GCT-3 0) [20]. The competitor oligonucleotides SRE,
SRE* (5 0-ACATGAACATACAAGGTATTGCAGCT-3 0) or
Act (5 0-CCAACATCATCACATGCACC-3 0) were added
to incubation mixtures 10 min before the labeled oligo-
nucleotide. As indicated for each experiment, 1 mL
antibody including anti-(mouse SRF) (G20; Santa Cruz
Biotechnology), anti-(mouse Myc) (C8; Santa Cruz Bio-
technology) or anti-(Drosophila SRF) was added to the
binding reaction mixture 10 min before the labeled
oligonucleotide. The binding reaction mixtures were
incubated at 4 8C for 20 min after addition of the
labeled oligonucleotide and analyzed on a 6% polyacryla-
mide gel [20].
Table 1. Transcriptional activity of A. franciscana Actin403 pro-
moter in cultured mammalian and D. melanogaster cells. The
mean ^ SD luciferase activity, normalized to the activity obtained
with the empty pXP2 vector, is presented for each cell line in relative
units.
NIH 3T3 N2A C2C12 Bsc40 Schneider
16.6 ^ 3.4 9.2 ^ 1.0 166.0 ^ 4.7 584.6 ^ 208.7 117.5 ^ 70.5
Fig. 1. Analyses of functional regions in the A. franciscana
Actin403 promoter. (A) Nucleotide sequence of the A. franciscana
Actin403 gene promoter with indication of the 5 0 end of the deletions
analyzed (D1±D8), shown as gaps in the sequence. The nucleotide
sequence is numbered from the protein translation initiation codon as
in Ortega et al. [8]. The putative CArG box is underlined. (B)
Transcriptional activity of the Actin403 promoter deletions. The
longest fragment available from the Actin403 promoter (D0) and the
deletions generated from it (D1±D8) were cloned in the pXP2
luciferase expression vector. The 5 0 end of each deletion was numbered
as shown in (A); the 3 0 end (nucleotide 238) was common to all
constructs. NIH3T3, Bsc40 and Schneider cells were cotransfected
with each of the reporter vectors, and a plasmid expressing
b-galactosidase was used to check for transfection efficiency.
Mean ^ SD luciferase/b-galactosidase activities obtained, relative to
those of the longest promoter fragment (D0  100), are indicated.
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R E S U LT S
Characterization of a CArG box in the A. franciscana
Actin403 promoter
Functionality of the A. franciscana Actin403 gene promoter
was analyzed by transient expression of a plasmid in which
a luciferase reporter gene was placed under the control of a
1323-nt fragment that included the first exon of the gene
and the immediate upstream region. Several mammalian
cell lines and Drosophila Schneider cells were tested for
reporter gene expression (Table 1). A significant induction
of luciferase activity, as compared with the vector without
promoter region, was observed in all cell lines tested,
indicating functionality of the A. franciscana promoter in
Drosophila and mammalian cells. Successive deletions of
the Actin403 promoter were generated from its 5 0 end and
tested for transcriptional activity to identify functional
regions. Deletion of a region between nucleotides 2176
and 2122 almost completely abolished promoter activity in
the three cell lines tested (Fig. 1B). This deletion eliminates
the first two nucleotides of a putative CArG box, suggesting
that this is an important functional region of the promoter.
To test this proposal, the CArG box was mutagenized
Fig. 2. Characterization of a putative SRE in the A. franciscana Actin403 promoter. (A) The putative Actin403 CArG box was mutated in
theD6 deletion vector (5 0-CcataTaagg-3 0 to 5 0-AcataCaagg-3 0). The luciferase reporter vector (±), the longest Actin403 promoter construct (D0), the
wild-type D6 deletion (D6), the mutated D6 deletion (D6mut) and the deletion D7 which interrupts the CArG box were cotransfected with the
b-galactosidase expression vector in NIH3T3 (left), Bsc40 (middle) or Schneider (right) cells. The relative luciferase activities obtained, corrected
by b-galactosidase expression, are shown. The value 100 was arbitrarily assigned to the D0 deletion. Bars represent standard deviations. (B) NIH
(left) and Bsc40 (right) cells were transfected with the luciferase reporter vector (±), the longest Actin403 promoter (D0), the D6 or D7 deletion
reporter constructs. Transfected cells were stimulated with fetal bovine serum (columns 1 serum) or left in 0.5% fetal bovine serum (columns ±
serum). The relative luciferase activities obtained are represented. The value 100 was assigned to the activity of the longest promoter construct (D0)
in cells maintained in 0.5% fetal bovine serum. Bars represent standard deviations. ***P , 0.001 compared without serum.
Fig. 3. SRF binding to the CArG box of the A. franciscana Actin403 promoter. Nuclear extracts obtained from either NIH3T3 (left) or
Schneider (right) cells were incubated with the 32P-labeled oligonucleotide SRE. A 100 times excess of the unlabeled oligonucleotides SRE, SRE*
(contains changes in the CArG box identical with those of the D6mut promoter deletion), the unrelated oligonucleotide Act or none (±) were used
as competitors. Anti-(mouse SRF) (aSRF), anti-(Drosophila SRF) (aDmSRF) or anti-(mouse Myc) (aMyc) was added to the incubation mixtures
in the indicated lanes. Arrows indicate the migration of the SRF-specific complexes. The asterisk indicates the position of the more slowerly
migrating complexes specifically obtained after incubation with a-SRF antibodies.
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in vitro. The first C of the CArG box was changed to A and
the sixth T was changed to C to impair SRF binding. The
promoter region with the modified CArG box was almost
completely inactive in NIH and Bsc40 cells (Fig. 2A)
showing that the CArG box is the main functional element
of the A. franciscana Actin403 promoter in cultured
mammalian cells. In Drosophila Schneider cells, mutation
of the CArG box reduced promoter activity significantly
although the D6mut promoter region still retained higher
promoter activity than D7 or the empty vector.
The importance of the A. franciscana CArG box was
further analyzed by studying the transcriptional response of
the promoter to stimulation with serum. Bsc40 and NIH3T3
cells were transfected with the reporter vector containing
the longest promoter fragment (D0), the more proximal
176 nt including the CArG box (D6), or the more proximal
122 nt (D7), of the Actin403 promoter. NIH3T3 cells
showed strong transcriptional activation by serum
(Fig. 2B). Bsc40 showed transcriptional activity in low
serum which was increased by serum (Fig. 2B). The
stimulations observed were similar for the longest promoter
region and fragment D6, but fragment D7, with a partially
deleted CArG box, showed very low transcriptional activity
and no serum stimulation.
Binding of SRF to the Actin403 CArG box
The above data suggested that the Actin403 promoter
contained a functional SRE, centered on the CArG box. To
further confirm this result, we determined if SRF bound to
this region of the promoter in vitro. EMSAs were
performed using oligonucleotides containing the Actin403
CArG box and nuclear extracts from NIH3T3 or Schneider
cells (Fig. 3). A more slowly migrating band was observed
in the presence of nuclear extracts which could be
specifically competed for with an excess of the same
unlabeled oligonucleotide but not with a similar oligo-
nucleotide containing the mutated CArG box sequence
(SRE*) or an unrelated oligonucleotide (Act). Incubation
with antibodies specific for mouse SRF (NIH) or Droso-
phila SRF (Schneider) further reduced the migration of the
band. From these experiments, we concluded that mamma-
lian and Drosophila SRF specifically recognized the CArG
box contained in the Actin403 promoter.
Conserved regulation of the SRE from the Actin403
promoter
The functional conservation of the A. franciscana SRE was
further analyzed by studying its capacity to mediate SRF-
dependent transcriptional responses of the reporter gene
under the activation of TCF-dependent and independent
pathways. F9, Bsc40 and NIH3T3 cells were transfected
with the reporter vector containing the most proximal
176 nt of the Actin403 promoter, including the CArG box
(D6), which showed somewhat higher serum activation than
the longest fragment analyzed (D0). Transfected cells were
stimulated with serum (fetal bovine serum), phorbol esters
(PDBu), or LPA, as indicated in Materials and methods. As
shown in Fig. 4A, the three treatments differentially
stimulated the transcriptional activity driven by the
Actin403 promoter in NIH3T3 and Bsc40 cells. In F9
cells, transcriptional activation was obtained in response to
serum or LPA, but not in response to PDBu (Fig. 4A), in
agreement with the described inactivity of the TCF
activation pathway in this cell line [21]. Bsc40 cells
showed significant transcriptional activity in low serum
which was increased by treatment with PDBu and LPA
(Fig. 4A). Finally, NIH3T3 cells showed strong transcrip-
tional activation by serum and lower levels of activation by
LPA and PDBu, respectively (Fig. 4A). The dependence of
the serum response on the CArG box was tested using the
Fig. 4. Stimulation of Actin403
promoter-driven transcription by serum,
phorbol esters and LPA. (A) Reporter
vectors containing the D6 Actin403 promoter
deletion were transfected into NIH (left),
Bsc40 (middle) or F9 (right) cells.
Transfected cells were stimulated with fetal
bovine serum, PDBu or LPA, as indicated in
Materials and methods. The luciferase
activities obtained, relative to the activities
obtained with serum (100), are shown. Bars
represent standard deviations of the data.
*P , 0.05; ***P , 0.001 ccompared with
controls. (B) NIH (left) or Bsc40 (right) cells
were transfected with the reporter vector
containing the D6 mutated promoter
construct. Stimulation of the cells with
serum, PDBu or LPA was as described in
Materials and methods. The luciferase
activities obtained, relative to activities with
the wild-type promoter in the presence of
serum (100; panel A), are shown. Bars
represent standard deviations of the data.
**P , 0.01; ***P , 0.001 compared with
controls.
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reporter vector with the mutated box (Fig. 4B). This vector
promoted much lower levels of luciferase expression
(compare the scale of relative luciferase activity in panels
A and B) and showed very low stimulation by serum, PDBu
and LPA in the cell lines tested. However, significant
activation by serum in NIH3T3 cells and PDBu in Bsc40
cells was observed with the mutated promoter.
D I S C U S S I O N
These results strongly suggest that a CArG box is essential
for activity of the A. franciscana Actin403 promoter in
mammalian cells. This conclusion is supported by the
analyses of progressive deletions of the promoter, as all the
deletions analyzed from 21362 to 2176 have similar
promoter activity, but it decreases between 16 and 77 times
for deletion 2122, which splits the CArG box. Similar loss
of activity is observed when only the CArG box is mutated.
It is very likely that activity of the Actin403 promoter is
mediated through binding of the SRF because mammalian
SRF specifically binds to the Actin403 promoter CArG box.
Moreover, binding is impaired by the same nucleotide
mutations that suppress promoter activity. The results do
not exclude the contribution of other regulatory elements to
the Actin403 promoter activity but they strongly suggest
that activation of the SRE is necessary for promoter
function. Other putative transcription factors could be
coactivators of SRF, as discussed below.
Analysis of the Actin403 promoter in Drosophila
Schneider cells shows the important contribution of the
CArG box in these cells, but the regulation is more complex
than in mammalian cells. Deletion of the region 2176 to
2122 decreased promoter activity 6.5-fold, but mutation of
the CArG box had a smaller effect, decreasing the activity
about threefold. These results could be explained if the
nucleotide changes introduced into the CArG box
decreased Drosophila SRF binding less than mammalian
SRF binding. However, EMSA experiments showed that the
mutated oligonucleotide did not compete significantly for
Drosophila SRF binding, suggesting that it has much lower
affinity for the mutated CArG box. Alternatively, there may
be other important regulatory sites in the Actin403 promoter
in the 2176 to 2122 region. Another difference in
Schneider cells is the large increase in activity observed
between deletions 2222 and 2176, which could be
explained by the presence in this region of binding sites
for one or more transcription inhibitory factors. The nature
of these possible repressors has not been investigated
further. Similar results have been described previously
for other promoters, such as the actin 5C [22,23] or the
d-aminolevulinate synthase [24] Drosophila promoters in
which deletion of some regions increased promoter activity.
There are no similarities in the nucleotide sequences of the
Actin403 ±222 to 2176 promoter region and those of the
other promoters mentioned above.
The relevance of the CArG box for activity of the
Actin403 promoter in mammalian and Drosophila cells
suggests that the region is important in the regulation of this
gene in Artemia. cDNA clones coding for an A. franciscana
SRF homolog, more than 96% identical with Drosophila
and vertebrate SRFs in their DNA-binding regions (MADS
boxes), have been isolated [7]. Moreover, both Actin403
and SRF mRNAs are coexpressed in the ectodermal tissues
of the nauplii, in accordance with the proposed relevance of
SRF in the regulation of the tissue-specific expression of
Actin403 [7]. CArG-binding activity has been detected in
A. franciscana nauplii that is very reduced in encysted
embryos, which is in agreement with the observed
induction of Actin403 mRNA expression during develop-
ment [4,7]. Unfortunately, no techniques have yet been
developed for transforming A. franciscana embryos, which
prevents further testing of this hypothesis.
The A. franciscana Actin403 promoter is regulated as an
SRE through the CArG box. The A. franciscana promoter
is activated by serum, phorbol esters and LPA, which
indicates its regulation by TCF-dependent and TCF-
independent pathways. The stimulations observed in
Bsc40 cells are much lower than those observed in NIH
cells, because of the high promoter activity observed in
Bsc40 cells cultured in 0.5% fetal bovine serum. This
activity could be due to a higher sensitivity of Bsc40 cells
to growth factors present in the serum or, perhaps, to the
secretion of growth factors by these cells through an
autocrine mechanism. Promoter activity and stimulation by
growth factors are markedly reduced, although not
completely abolished, by mutation of the CArG box on
the Actin403 promoter, as shown in Fig. 4B. The low
activity of the mutated promoter could be explained by
stimulation through SRF-independent pathways. Alterna-
tively, the results could be explained by residual low-
affinity binding of SRF to the mutated CArG box.
Both TCF-dependent and TCF-independent pathways
require the association of SRF on the promoter with other
transcription factors, either the TCF family of factors (Elk1,
Sap1a, Sap2) [25] or other factors such as MHox and
Nkx-2.5 [26,27]. We do not know if any of these factors
bind to the Actin403 promoter region. Alternatively, some
cofactors could bind SRF through protein±protein inter-
actions, without DNA binding [28,29]. Although these
interactions still have to be defined, the results suggest
conservation of SRF regulatory pathways between verte-
brates and invertebrates. Some of the data obtained with
Drosophila Schneider cells support this hypothesis.
Actin403 promoter activity in Schneider cells is partially
dependent on the CArG box, and binding of Drosophila
SRF from Schneider extracts is observed in EMSAs.
Binding specificity is demonstrated by the lack of
competition of the CArG mutated oligonucleotide and by
the supershift produced after incubation with monoclonal
antibodies to Drosophila SRF. The possible stimulation of
Actin403 promoter by serum could not be studied in
Schneider cells because of their high mortality in low
serum.
SRF is necessary for proper development of Drosophila
terminal tracheal cells and wing intervein regions [30,31].
The expression and functionality of SRF in Schneider cells
suggests that this transcription factor has a role in
proliferating Drosophila cells, although no defect in cell
proliferation has been observed in SRF mutants. These
results resemble those obtained in Srf knock-out mouse
strains which display a severe defect in gastrulation [11],
but embryonic stem cells obtained from these mice showed
normal rates of proliferation [32]. However, SRF has been
shown to have an important role in mammalian cell cycle
progression [9,25]. Similarly, the data obtained in
Drosophila Schneider cells suggest that SRF could also
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play a significant role in regulation of cell proliferation in
invertebrates, although more experiments are needed to test
this hypothesis.
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